AIG
ORMP icon

American International Group’s Oramed Pharmaceuticals ORMP Stock Holding History

American International Group’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,522
Closed -$160K – 3218
2022
Q1 		$160K Buy
18,522
+2,413
+15% +$24.7K ﹤0.01% 2378
2021
Q4 		$230K Sell
16,109
-482
-3% -$10.1K ﹤0.01% 2285
2021
Q3 		$365K Buy
16,591
+1,622
+11% +$27.6K ﹤0.01% 2051
2021
Q2 		$200 Buy
+14,969
New +$171K ﹤0.01% 2504

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American International Group's ORMP Position: Q2 2022 in Review

American International Group sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 18,522 shares — an estimated $160K sold.

American International Group first reported a position in ORMP in Q2 2021 and held it in 4 quarters. The position peaked at $365K in Q3 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

  • American International Group reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 18,522 Oramed Pharmaceuticals shares in Q2 2022, an estimated $160K.
  • American International Group first reported a position in Oramed Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • American International Group's Oramed Pharmaceuticals position peaked at $365K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.